Eyestem raises Series A round from Biological E, Alkem, NATCO, Kemwell promoters and existing investors- Kotak and Endiya Learn More
Eyestem Research moves one step closer in finding a treatment for Dry AMD and announces successful animal experiments for its flagship product. Learn More
Eyestem announces award of its US patent for creation of Retinal Pigment Epithelium, Photoreceptors and Retinal Organoids Learn More
Eyestem announces second round of funding for Eyecyte-RPETM from Kotak Private Equity and original investors Learn More
CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad & Eyestem Research Private Limited, Bangalore announce a unique public-private collaboration in the fight against Covid-19 Learn More
Eyestem Research announces immediate availability of its Anti-Covid Screening (ACS) platform using iPSC derived lung progenitors Learn More
Eyestem Research, India’s premier cell therapy company, announces successful completion of pre-IND meeting with FDA Learn More
